Sermorelin

Sermorelin is a synthetic research peptide comprising the first 29 amino acids of growth hormone-releasing hormone (GHRH 1-44), representing the biologically active domain responsible for receptor binding and physiologic growth hormone stimulation. In laboratory and controlled clinical research, Sermorelin binds to the GHRH receptor on pituitary somatotrophs, activating adenylate cyclase and cAMP-dependent signaling pathways that regulate growth hormone (GH) synthesis and pulsatile release. As a short-acting GHRH analog, it is utilized in studies investigating hypothalamic-pituitary axis regulation, endocrine feedback mechanisms, and somatotropic signaling specificity.

In vitro systems and structured clinical investigations evaluate endpoints including GH secretion dynamics, receptor binding affinity, intracellular cAMP activation, downstream insulin-like growth factor-1 (IGF-1) response patterns, and pharmacokinetic profiles relative to baseline measures.